BiotechTubeBiotechTube
Home/Rapport Therapeutics/Katherine (Kate) Tenaerts
K(

Katherine (Kate) Tenaerts

Chief Business Officer

Rapport Therapeutics

Therapeutic Areas

NeurosciencePsychiatryEpilepsyAnxiety DisordersCognitive Disorders

Rapport Therapeutics Pipeline

DrugIndicationPhase
RAP-219Drug-Resistant Focal EpilepsyPhase 1b/2a
Undisclosed GABA-A RAP ProgramAnxiety DisordersDiscovery
Undisclosed AMPA RAP ProgramCognitive ImpairmentDiscovery

Leadership Team at Rapport Therapeutics

A(
Abraham (Avri) C. C. C. C. C.
Chief Executive Officer & Director
DB
David Bredt
Chief Scientific Officer & Head of R&D
WD
Wendy DiCicco
Chief Operating Officer & Chief Financial Officer
RM
Ramy Mahmoud
Chief Medical Officer
CR
Carlo Rizzuto
Chairman of the Board, Partner at Third Rock Ventures
KS
Kevin Starr
Board Director, Partner at Third Rock Ventures
AC
Abbie Celniker
Board Director, Partner at Third Rock Ventures
LR
Liam Ratcliffe
Board Director, Managing Director at New Enterprise Associates (NEA)
KY
Krishna Yeshwant
Board Director, General Partner at Google Ventures (GV)
SM
Stephen Moss
Scientific Founder, Professor at Tufts University
View full Rapport Therapeutics profile